All Cancer articles – Page 3
-
News
C difficile rates hit 13-year high
C difficile cases rose to their highest level in more than a decade, official data published this month shows.
-
HSJ Partners
Capacity-sparing innovations in blood cancer could unlock NHS potential
Toby Kent of AbbVie UK highlights how the forthcoming NHS 10-year plan is a crucial opportunity to set out a vision for medicines’ role as capacity-sparing innovations which could reduce pressures on infusion services in blood cancer and improve treatment choices for people affected by cancer.
-
Comment
Being a patient taught me things I hadn’t learned as a trust CEO
NHS CEO’s patient journey helps him realise the strengths of the NHS and areas requiring improvement, particularly in EDI and the use of emerging technologies
-
HSJ Local
Staff ‘rebuked’ for raising safety concerns despite patient deaths
Staff were ‘rebuked’ for raising safety concerns at a trust where the incorrect use of chemotherapy has been linked to patient deaths, HSJ has discovered.
-
Comment
Changing the shape of services key to eliminating cervical cancer
NHS leaders, services, and health professionals must listen to women’s experiences to collect better data for meeting the new goal of ending cervical cancer by 2040, writes Rebecca Curtayne, External Affairs manager at Healthwatch England
-
HSJ Awards
HSJ Patient Safety Awards 2024: Community Care Initiative of the Year
WINNER Cheshire and Merseyside Cancer Alliance: Community Partnerships: Community ownership of cancer information to increase timely presentation
-
HSJ Awards
HSJ Patient Safety Awards 2024: Improving Care for Older People Initiative of the Year
WINNER The Royal Marsden FT: The Senior Adult Oncology Programme
-
News
Trust claims ‘stressed’ staff are quitting over faulty IT system
An acute trust has claimed “experienced and dedicated staff” have quit their roles because of “the stress and anxiety caused by the instability” of its imaging IT system as its row with a private provider intensifies.
-
News
‘Unrealistic’ new targets set for cancer tests
New activity targets set for community diagnostic centres this month will not be met on current staffing levels, experts have warned.
-
Daily Insight
The mythbuster: Health screening is a suspect policy
The evidence says many screening programmes are actively detrimental, while others are a waste of money writes Steve Black
-
News
Streeting pressed for decision on controversial service change
Wes Streeting will have to consider whether to “call in” a long-awaited, contested restructure of children’s cancer services in south London.
-
Comment
Labour’s inheritance on RTT waiting times
At the end of the last government, waiting times were bad but no longer getting worse.
-
News
Trust seeks more income to shore up planned cancer centre
A trust’s £750m redevelopment project is facing an “affordability challenge”, raising questions over a proposed new cancer centre.
-
HSJ Partners
How can NHS and industry partnerships transform patient care?
Rachel Houlding, national oncology healthcare director at MSD, discusses highlights from a recent award-winning NHS partnership that could help you to transform your patient pathways
-
HSJ Partners
A model of efficiency: Reducing cancelled procedures with digital prep support
One in 20 colonoscopies do not go ahead as planned due to poor or insufficient prep. King’s College Hospital’s Mayur Kumar explains how his trust worked with Healthcare Communications to reduce cancellations by 28 per cent, saving £336,000 a year.
-
News
Cancer treatment ‘biased against ethnic minorities’
A type of cancer treatment used in the NHS appears to be biased against non white European patients, research has found.
-
Comment
Why a focus on waiting time targets may neglect the poorest cancer patients
Naser Turabi explains how ensuring equitable access to cancer treatment is crucial.
-
HSJ Partners
Cross-pathway efforts are needed to optimise multi-modality treatment for non-small cell lung cancer
After decades with little progress, the treatment landscape for lung cancer has dramatically transformed. However, experts at a roundtable event highlighted that the NHS is struggling to keep up with such rapid progress, and changes across the pathway are urgently needed to optimise outcomes from multi-modality treatment.
-
HSJ Partners
Could better screening reduce the slide in UK cancer outcomes?
Deloitte sheds light on the barriers faced by vulnerable populations, disparities in cancer screening, and strategies for equitable access.
-
News
Streeting commits to hit four-hour target in first term
Wes Streeting has reiterated Labour’s commitment to hitting all the NHS’s headline performance standards in its first term, including the four-hour A&E target, if it wins power.